These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 13488122)

  • 1. [Absorption of anti-Kell antibodies by dried blood].
    DUCOS J
    Ann Med Leg Criminol Police Sci Toxicol; 1957; 37(4):171-7. PubMed ID: 13488122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of soluble recombinant proteins with Kell, Duffy and Lutheran blood group antigen activity, and their use in screening human sera for Kell, Duffy and Lutheran antibodies.
    Ridgwell K; Dixey J; Scott ML
    Transfus Med; 2007 Oct; 17(5):384-94. PubMed ID: 17725551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Absorption of anti-Fya antibodies by dried blood].
    RUFFIE J; DUCOS J
    C R Seances Soc Biol Fil; 1957; 151(2):393-5. PubMed ID: 13473280
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti Kell allo-antibody in a thalassaemic.
    Thakral B; Saluja K; Sharma RR; Marwaha N; Marwaha RK
    Indian J Pathol Microbiol; 2006 Jan; 49(1):37-9. PubMed ID: 16625974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-Kell isoimmunization].
    KOUT M; ENDERLE E
    Cas Lek Cesk; 1963 Mar; 102():264-7. PubMed ID: 14035143
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.
    Lee S; Debnath AK; Wu X; Scofield T; George T; Kakaiya R; Yogore MG; Sausais L; Yacob M; Lomas-Francis C; Reid ME
    Transfusion; 2006 Aug; 46(8):1323-7. PubMed ID: 16934067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the presence or absence of J chain on expression of recombinant anti-Kell immunoglobulin M.
    Gilmour JE; Pittman S; Nesbitt R; Scott ML
    Transfus Med; 2008 Jun; 18(3):167-74. PubMed ID: 18598279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
    Mannessier L
    Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of expression of the components of the Kell blood group complex.
    Pu JJ; Redman CM; Visser JW; Lee S
    Transfusion; 2005 Jun; 45(6):969-74. PubMed ID: 15934996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system.
    Clapéron A; Hattab C; Armand V; Trottier S; Bertrand O; Ouimet T
    Brain Res; 2007 May; 1147():12-24. PubMed ID: 17379193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Utilization of papinized erythrocytes for the detection of anti-A and anti-B antibodies in dried blood stains].
    DUCOS J
    Ann Med Leg Criminol Police Sci Toxicol; 1960; 40():519-21. PubMed ID: 13724740
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation.
    Cheng HJ; Lei HY; Lin CF; Luo YH; Wan SW; Liu HS; Yeh TM; Lin YS
    Mol Immunol; 2009 Dec; 47(2-3):398-406. PubMed ID: 19822367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report on the 13th International Society of Blood Transfusion Platelet Immunology Workshop.
    Foxcroft Z; Campbell K; Merieux Y; Urbaniak S; Brierley M; Rigal D; Ouwehand WH; Metcalfe P;
    Vox Sang; 2007 Nov; 93(4):300-5. PubMed ID: 18070273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal human serum contains high levels of anti-Gal alpha 1-4GlcNAc antibodies.
    Obukhova P; Rieben R; Bovin N
    Xenotransplantation; 2007 Nov; 14(6):627-35. PubMed ID: 17991151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.